Walgreen Co., now a subsidiary of Walgreen Boots Alliance, Inc., has announced it will sell a majority interest in Walgreen Infusion Services (WIS) to a private equity firm for an undisclosed sum. WIS has alternate treatment sites in 40 states and the ability to serve 90 percent of the US population. Madison Dearborn Partners (MDP), a Chicago-based private equity firm, has agreed to the purchase that will result in WIS becoming a new independent, privately held company.
Featured News
California AG Says No Paramount Settlement Talks Scheduled
Aug 25, 2026 by
CPI
Judge Lets Antitrust Case Against 32 US Universities Move Forward
Aug 25, 2026 by
CPI
CoStar Hit With Consolidated Antitrust Challenge Over Property Data
Aug 25, 2026 by
CPI
Express Scripts Wins Dismissal of Nonprofit Pharmacy’s Antitrust Claims
Aug 25, 2026 by
CPI
Draghi, Business Leaders Form Group Focused on European Competitiveness
Aug 25, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Antitrust Antipasto
Aug 24, 2026 by
CPI
“Anti-Monopoly” Antitrust Enforcement: Lessons Learned from the Biden Administration
Aug 24, 2026 by
Diana L. Moss
FTC v. Meta: The Importance of Quantitative Evidence in Antitrust
Aug 24, 2026 by
Dennis Carlton, John A. List, Allan Shampine, Hal Sider & Theresa Sullivan
Competitor Information Exchanges: Reducing Market Uncertainty Is What Matters, Not Level Of Detail
Aug 24, 2026 by
Kasia Czapracka, Assimakis Komninos, James Killick & Nina Frie
When Politics Meets Merger Control: 10 Transatlantic Takeaways
Aug 24, 2026 by
Rachel Brandenburger